background
multipl
sclerosi
ms
one
common
diseas
central
nervou
system
cn
character
demyelin
chronic
inflamm
cn
failur
immun
toler
induc
autoimmun
process
involv
ms
immunopathogenesi
regulatori
treg
cell
play
import
role
maintain
peripher
toler
immun
homeostasi
object
aim
studi
evalu
frequenc
high
treg
cell
ms
patient
method
studi
popul
compos
healthi
control
hc
patient
relaps
remit
multipl
sclerosi
rrm
patient
progress
multipl
sclerosi
pm
frequenc
high
treg
cell
rrm
pm
patient
compar
hc
flow
cytometri
result
treg
cell
frequenc
pm
patient
significantli
higher
compar
rrm
patient
p
hc
p
lower
rrm
patient
hc
p
signific
direct
correl
treg
cell
frequenc
expand
disabl
statu
scale
edss
pm
patient
p
r
observ
revers
correl
treg
cell
frequenc
edss
rrm
patient
found
p
r
conclus
detail
clarif
role
treg
cell
ms
patient
could
provid
basi
develop
treg
cellsmedi
therapeut
strategi
multipl
sclerosi
ms
one
common
autoimmun
debilit
neurolog
diseas
character
demyelin
chronic
inflamm
cn
trapp
nave
two
main
categori
ms
relaps
remit
multipl
sclerosi
rrm
progress
multipl
sclerosi
pm
rrm
common
type
typifi
irregular
relaps
follow
monthandyearperiod
rel
quiet
without
symptom
clinic
isol
syndrom
ci
fulfil
ms
criteria
frequent
start
point
pm
includ
three
type
secondari
progress
multipl
sclerosi
spm
primari
progress
multipl
sclerosi
ppm
progress
relaps
multipl
sclerosi
prm
hawk
giovannoni
confavreux
vukus
etiolog
ms
clearli
genet
environment
immunolog
factor
virus
eg
ebv
cmv
hbv
hsv
human
herpet
virus
measl
virus
coronavirus
may
role
occurr
ms
sospedra
martin
myelin
sheath
surround
nerv
fiber
damag
ms
jiang
chess
dendrou
et
al
major
immun
cell
involv
immunopathogenesi
ms
cell
especi
amount
cell
associ
cytokin
eg
interferon
gamma
tumor
necrosi
factor
shown
increas
ms
patient
raphael
et
al
li
et
al
recent
year
becam
clear
treg
cell
also
particip
immunopathogenesi
ms
buc
treg
cell
essenti
http
receiv
juli
accept
juli
maintain
peripher
toler
self
antigen
varieti
solubl
mediat
includ
cell
surfac
molecul
tai
et
al
collison
et
al
multipl
treg
subset
varieti
suppress
mechan
treg
cell
decreas
activ
expans
convent
cell
suppress
biolog
activ
inhibit
prolifer
block
product
proinflammatori
cytokin
liu
lan
et
al
quantit
function
defect
treg
cell
associ
mani
autoimmun
diseas
includ
ms
rheumatoid
arter
ra
type
diabet
sakaguchi
et
al
long
buckner
role
treg
cell
ms
controversi
sever
studi
report
decreas
treg
cell
frequenc
ms
patient
huan
et
al
haa
et
al
venken
et
al
kouchaki
et
al
number
studi
report
frequenc
compar
healthi
subject
venken
et
al
haa
et
al
feger
et
al
viglietta
et
al
frisullo
et
al
moreov
studi
indic
function
defect
treg
cell
venken
et
al
haa
et
al
feger
et
al
frisullo
et
al
venken
et
al
studi
need
understand
potenti
tregbas
therapi
ms
patient
studi
determin
frequenc
high
treg
cell
rrm
pm
patient
compar
tohc
ahvaz
center
khuzestan
provinc
host
live
far
arab
ethnic
popul
blood
sampl
taken
patient
healthi
control
sign
inform
consent
studi
approv
ethic
committe
ahvaz
jundishapur
univers
medic
scienc
peripher
blood
sampl
obtain
patient
ms
hc
age
sex
match
golestan
hospit
ahvaz
iran
diagnosi
base
clinic
trial
magnet
reson
imag
mri
accord
mcdonald
criteria
polman
et
al
diagnos
either
rrm
pm
none
patient
hc
suffer
autoimmun
diseas
inflammatori
statu
ms
patient
either
untreat
treatment
cinovex
rebif
betaseron
methotrex
glatiram
acet
ga
time
blood
sampl
blood
sampl
ms
patient
obtain
clinic
stabl
phase
remiss
least
month
last
activ
relaps
edss
score
diseas
durat
ask
time
blood
sampl
accord
standard
scale
edss
patient
scale
determin
neurologist
peripher
blood
mononuclear
cell
pbmc
isol
ml
heparin
blood
sampl
ficollhypaqu
densiti
gradient
centrifug
densiti
sigma
germani
patient
hc
antibodi
purchas
ebiosci
compani
ebiosci
usa
cell
stain
accord
manufactur
instruct
pbmc
incub
min
monoclon
antibodi
cell
wash
twice
phosphatebuff
salin
pb
resuspend
pb
store
dark
prior
flow
cytometri
analysi
monoclon
antibodi
use
follow
fitcconjug
mous
antihuman
clone
peconjug
mous
antihuman
clone
apcconjug
mous
antihuman
clone
mous
k
isotyp
control
fitc
clone
mous
k
isotyp
control
pe
clone
mous
k
isotyp
control
apc
clone
use
isotyp
control
cell
analyz
use
flow
cytometri
becton
dickinson
san
diego
ca
usa
least
event
record
sampl
data
analyz
softwar
tree
star
ashland
usa
statist
analysi
done
spss
version
spss
inc
chicago
il
usa
comparison
treg
cell
frequenc
differ
group
patient
hc
perform
use
oneway
analysi
varianc
anova
tukey
post
hoc
test
correl
paramet
calcul
pearson
correl
coeffici
test
independ
ttest
data
express
mean
standard
error
mean
pvalu
consid
signific
demograph
clinic
characterist
ms
patient
hc
shown
tabl
patient
due
expens
medicin
econom
condit
could
suppli
medicin
consid
treatment
singl
marker
describ
treg
cell
popul
defin
flow
cytometri
high
cell
fig
lower
frequenc
treg
cell
rrm
patient
subject
age
sex
match
hc
observ
vs
p
differ
cell
frequenc
rrm
patient
hc
vs
p
vs
p
respect
shown
fig
treg
cell
frequenc
pm
patient
significantli
higher
rrm
patient
hc
vs
respect
p
case
also
cell
frequenc
pm
patient
significantli
higher
hc
vs
p
frequenc
cell
pm
patient
versu
hc
differ
vs
p
fig
correl
treg
cell
frequenc
age
sex
ethnic
rrm
pm
patient
data
shown
use
pearson
correl
coeffici
test
signific
invers
correl
treg
cell
frequenc
edss
rrm
patient
observ
p
r
correl
treg
cell
frequenc
diseas
durat
p
r
direct
correl
treg
cell
frequenc
edss
diseas
durat
pm
patient
shown
p
r
p
r
respect
shown
tabl
previou
studi
controversi
result
qualiti
quantiti
treg
cell
ms
patient
often
character
treg
cell
base
quantif
cell
obtain
frequenc
way
actual
valu
activ
cell
without
regulatori
activ
upregul
express
allan
et
al
tran
et
al
rule
phenomena
use
combin
high
express
low
level
express
identif
treg
cell
peripher
blood
seddiki
et
al
liu
et
al
studi
shown
high
treg
cell
frequenc
rrm
patient
significantli
lower
pm
patient
hc
accord
result
other
demonstr
treg
cell
frequenc
reduc
rrm
patient
compar
hc
huan
et
al
haa
et
al
venken
et
al
kouchaki
et
al
reduc
number
treg
cell
consid
possibl
reason
onset
ms
predispos
factor
venken
et
al
namdar
et
al
consist
observ
may
due
clonal
function
exhaust
migrat
potent
suppressor
cell
rrm
patient
inflammatori
site
function
frequenc
treg
cell
lower
rrm
patient
rather
pm
patient
venken
et
al
shown
eae
model
cn
remiss
treg
cell
high
suppress
capac
kouchaki
et
al
report
accord
observ
high
level
express
treg
cell
venken
et
al
detect
high
cell
csf
rrm
patient
haa
et
al
accord
studi
treg
cell
frequenc
significantli
differ
ms
patient
comparison
hc
venken
et
al
haa
et
al
feger
et
al
viglietta
et
al
frisullo
et
al
studi
shown
even
number
treg
cell
ms
patient
normal
function
normal
venken
et
al
haa
et
al
feger
et
al
frisullo
et
al
venken
et
al
lower
treg
suppress
capabl
may
caus
increas
product
proinflammatori
cytokin
instanc
activ
b
cellsproduc
autoantibodi
via
contactdepend
contactindepend
suppress
effector
cell
teff
known
produc
treg
cell
usual
suppress
product
proinflammatori
cytokin
wang
et
al
van
mierlo
et
al
studi
also
report
reduct
treg
cell
frequenc
ms
patient
necessarili
rrm
patient
kouchaki
et
al
show
reduct
treg
cell
frequenc
ms
patient
compar
hc
refer
higher
frequenc
cell
sever
type
spm
ppm
rpm
compar
milder
type
rrm
ci
kouchaki
et
al
mark
paradox
result
differ
studi
due
differ
sampl
size
patient
characterist
differ
includ
exclud
criteria
differ
patient
categori
compar
marker
treg
identif
method
use
far
clear
indic
treg
cell
frequenc
pm
patient
studi
found
signific
increas
treg
cell
frequenc
pm
patient
compar
rrm
patient
hc
increas
frequenc
treg
cell
pm
patient
may
defens
approach
progress
trend
diseas
immun
system
increas
treg
cell
control
selfreact
cell
inflamm
neg
feedback
take
account
report
treg
cell
increas
elderli
kouchaki
et
al
venken
et
al
also
earli
immunesenesc
ms
diseas
similar
autoimmun
haa
et
al
feger
et
al
enhanc
treg
cell
may
occur
result
prematur
activ
mechan
normal
caus
immunesenesc
elderli
peopl
studi
demonstr
treg
cell
properli
infiltr
cn
diseas
cours
de
oliveira
et
al
et
al
fritzsch
et
al
ineffici
migrat
treg
cell
neuroinflammatori
site
lead
profound
implic
keil
et
al
buckner
ineffici
migrat
reason
higher
frequenc
tre
cell
pm
patient
compar
rrm
patient
hc
present
studi
seen
signific
direct
correl
treg
cell
frequenc
edss
diseas
durat
pm
patient
venken
et
al
express
like
restor
function
treg
cell
among
pm
patient
relat
longdur
treatment
venken
et
al
increas
treg
cell
frequenc
pm
patient
may
also
due
diseas
durat
longdur
treatment
shown
invers
correl
treg
cell
frequenc
edss
remiss
rrm
patient
result
agreement
invers
correl
treg
cell
frequenc
edss
remiss
ms
patient
note
studi
conduct
bjerg
et
al
anoth
studi
report
relaps
ms
patient
found
direct
correl
frequenc
treg
cell
diseas
durat
pm
patient
rrm
sinc
patient
spm
relaps
remit
cours
diseas
onset
strong
correl
activ
treg
cell
diseas
durat
earli
phase
diseas
function
treg
cell
seemingli
affect
li
et
al
one
report
enhanc
frequenc
treg
cell
also
seen
function
diseas
durat
liu
studi
shown
signific
correl
treg
cell
frequenc
age
sex
ethnic
rrm
pm
patient
studi
quantit
comparison
done
treg
cell
rrm
pm
patient
healthi
control
via
marker
first
time
author
declar
conflict
interest
